Terms: = Leukemia AND IL7R, P16871, IL-7R-alpha, CDW127, CD127, ENSG00000168685, 3575 AND Diagnosis
17 results:
1. Low il7r Expression at diagnosis Predicted Relapse in Adult Acute Myeloid leukemia Patients With t(8;21).
Xu N; Sun K; Wang YZ; Chen WM; Wang J; Li LD; Wang X; Hao Y; Chang Y; Liu YR; Huang XJ; Qin YZ
Front Immunol; 2022; 13():909104. PubMed ID: 35874754
[TBL] [Abstract] [Full Text] [Related]
2. Pediatric T-ALL type-1 and type-2 relapses develop along distinct pathways of clonal evolution.
Richter-Pechańska P; Kunz JB; Rausch T; Erarslan-Uysal B; Bornhauser B; Frismantas V; Assenov Y; Zimmermann M; Happich M; von Knebel-Doeberitz C; von Neuhoff N; Köhler R; Stanulla M; Schrappe M; Cario G; Escherich G; Kirschner-Schwabe R; Eckert C; Avigad S; Pfister SM; Muckenthaler MU; Bourquin JP; Korbel JO; Kulozik AE
Leukemia; 2022 Jul; 36(7):1759-1768. PubMed ID: 35585141
[TBL] [Abstract] [Full Text] [Related]
3. Increased frequency of TIGIT
Brauneck F; Haag F; Woost R; Wildner N; Tolosa E; Rissiek A; Vohwinkel G; Wellbrock J; Bokemeyer C; Schulze Zur Wiesch J; Ackermann C; Fiedler W
Oncoimmunology; 2021 Jun; 10(1):1930391. PubMed ID: 34211801
[TBL] [Abstract] [Full Text] [Related]
4. [Analysis of Clinical Characteristics and Therapeutic Efficacy of Patients with Adult Acute Lymphoblastic leukemia].
Xu TT; Wang WM; Fu GM; Wang JM; Jiang ZX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):68-75. PubMed ID: 32027255
[TBL] [Abstract] [Full Text] [Related]
5. Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia.
Forero-Castro M; Robledo C; Benito R; Bodega-Mayor I; Rapado I; Hernández-Sánchez M; Abáigar M; Maria Hernández-Sánchez J; Quijada-Álamo M; María Sánchez-Pina J; Sala-Valdés M; Araujo-Silva F; Kohlmann A; Luis Fuster J; Arefi M; de Las Heras N; Riesco S; Rodríguez JN; Hermosín L; Ribera J; Camos Guijosa M; Ramírez M; de Heredia Rubio CD; Barragán E; Martínez J; Ribera JM; Fernández-Ruiz E; Hernández-Rivas JM
Br J Cancer; 2017 Jul; 117(2):256-265. PubMed ID: 28557976
[TBL] [Abstract] [Full Text] [Related]
6. Identification of a genetically defined ultra-high-risk group in relapsed pediatric T-lymphoblastic leukemia.
Richter-Pechańska P; Kunz JB; Hof J; Zimmermann M; Rausch T; Bandapalli OR; Orlova E; Scapinello G; Sagi JC; Stanulla M; Schrappe M; Cario G; Kirschner-Schwabe R; Eckert C; Benes V; Korbel JO; Muckenthaler MU; Kulozik AE
Blood Cancer J; 2017 Feb; 7(2):e523. PubMed ID: 28157215
[TBL] [Abstract] [Full Text] [Related]
7. Risk stratification of adult T-cell leukemia/lymphoma using immunophenotyping.
Kagdi HH; Demontis MA; Fields PA; Ramos JC; Bangham CR; Taylor GP
Cancer Med; 2017 Jan; 6(1):298-309. PubMed ID: 28035765
[TBL] [Abstract] [Full Text] [Related]
8. Immunophenotyping with CD135 and CD117 predicts the FLT3, IL-7R and TLX3 gene mutations in childhood T-cell acute leukemia.
Noronha EP; Andrade FG; Zampier C; de Andrade CF; Terra-Granado E; Pombo-de-Oliveira MS;
Blood Cells Mol Dis; 2016 Mar; 57():74-80. PubMed ID: 26852660
[TBL] [Abstract] [Full Text] [Related]
9. Clinical significance of Treg cell frequency in acute myeloid leukemia.
Yang W; Xu Y
Int J Hematol; 2013 Nov; 98(5):558-62. PubMed ID: 24142765
[TBL] [Abstract] [Full Text] [Related]
10. Individualized leukemia cell-population profiles in common B-cell acute lymphoblastic leukemia patients.
Yu JH; Dong JT; Jia YQ; Jiang NG; Zeng TT; Xu H; Mo XM; Meng WT
Chin J Cancer; 2013 Apr; 32(4):213-23. PubMed ID: 22776235
[TBL] [Abstract] [Full Text] [Related]
11. Elevated frequencies of CD4⁺ CD25⁺ cd127lo regulatory T cells is associated to poor prognosis in patients with acute myeloid leukemia.
Shenghui Z; Yixiang H; Jianbo W; Kang Y; Laixi B; Yan Z; Xi X
Int J Cancer; 2011 Sep; 129(6):1373-81. PubMed ID: 21105040
[TBL] [Abstract] [Full Text] [Related]
12. [Change of CD4(+) CD25(+) regulatory T cells and NK Cells in peripheral blood of children with acute leukemia and its possible significance in tumor immunity].
Wu ZL; Hu GY; Chen FX; Lu HM; Wu ZL; Li HM; Wei FG; Guan JM; Wu LP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):709-13. PubMed ID: 20561434
[TBL] [Abstract] [Full Text] [Related]
13. Gene-based outcome prediction in multiple cohorts of pediatric T-cell acute lymphoblastic leukemia: a Children's Oncology Group study.
Cleaver AL; Beesley AH; Firth MJ; Sturges NC; O'Leary RA; Hunger SP; Baker DL; Kees UR
Mol Cancer; 2010 May; 9():105. PubMed ID: 20459861
[TBL] [Abstract] [Full Text] [Related]
14. [Prognostic significance of leukemia-associated phenotype in correlation with other biologic markers in acute myeloid leukemia patients].
Dăscălescu A; Zlei M; Grigore G; Dănăila C; Jitaru D; Carasevici E
Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1176-81. PubMed ID: 20191895
[TBL] [Abstract] [Full Text] [Related]
15. Allogeneic bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemia.
Toze CL; Shepherd JD; Connors JM; Voss NJ; Gascoyne RD; Hogge DE; Klingemann HG; Nantel SH; Nevill TJ; Phillips GL; Reece DE; Sutherland HJ; Barnett MJ
Bone Marrow Transplant; 2000 Mar; 25(6):605-12. PubMed ID: 10734294
[TBL] [Abstract] [Full Text] [Related]
16. Myeloperoxidase positive acute lymphoblastic leukemia cell lines, NALM-30, NALM-31 and NALM-32, carrying Philadelphia chromosome with biphenotypic characteristics.
Matsuo Y; Sugimoto A; Harashima A; Nishizaki C; Drexler HG; Orita K
Hum Cell; 1998 Dec; 11(4):221-30. PubMed ID: 10363160
[TBL] [Abstract] [Full Text] [Related]
17. Proliferation of MIELIKI a novel t(7;9) early pre-B acute lymphoblastic leukemia cell line is inhibited concomitantly by IL-4 and IL-7.
Renard N; Duvert V; Matthews DJ; Pagés MP; Magaud JP; Manel AM; Pandrau-Garcia D; Philippe N; Banchereau J; Saeland S
Leukemia; 1995 Jul; 9(7):1219-26. PubMed ID: 7630198
[TBL] [Abstract] [Full Text] [Related]
